Suchergebnisse - "Brian Gastman"

1

197 Survival outcomes and toxicity among patients treated with concomitant radiotherapy and immunotherapy for advanced melanoma: two faces of the abscopal effect?

von: Brian Gastman

2020, in: Journal for ImmunoTherapy of Cancer

Wird geladen...
2

Abstract 176: ICG-fluorescence Imaging With Lymphoscintigraphy For Sentinel Node Biopsy In Melanoma: Reducing The False Negative Rate

von: Rebecca Knackstedt

2020, in: Plastic and Reconstructive Surgery, Global Open

Wird geladen...
3

The Number of Nodes Examined in the Sentinel Lymph Node Biopsy Dictates Melanoma Survival

von: Daniela Duarte Bateman, MD

2023, in: Plastic and Reconstructive Surgery, Global Open

Wird geladen...
4

Prophylactic Lymphovenous Anastomosis Performed during Complete Lymphadenectomy Does Not Increase Risk of Distant Metastasis

von: Cagri Cakmakoglu, MD

2021, in: Plastic and Reconstructive Surgery, Global Open

Wird geladen...
5

224 Outcomes of stage IV melanoma in the era of immunotherapy: a national cancer database (NCDB) analysis

von: Wei Wei

2020, in: Journal for ImmunoTherapy of Cancer

Wird geladen...
6

Oncolytic Adenoviruses: The Cold War against Cancer Finally Turns Hot

von: Bryan Oronsky

2022, in: Cancers

Wird geladen...
7

Predictors of Complications following Forehead Flaps for Nasal and Periorbital Reconstruction

von: Viren Patel, MD

2022, in: Plastic and Reconstructive Surgery, Global Open

Wird geladen...
8

P122. LYMPHATICOVENOUS ANASTOMOSIS DOES NOT INCREASE RECURRENCE RISK IN MELANOMA

von: Thomas Y. Xia, BS

2022, in: Plastic and Reconstructive Surgery, Global Open

Wird geladen...
9

Abstract: Intraoperative Vasopressor Use in Free Flap Reconstruction Is Safe and Reduces Postoperative Flap Congestion

von: Danielle Christine Marshall, BA

2018, in: Plastic and Reconstructive Surgery, Global Open

Wird geladen...
10

P69. TEN-YEAR INSTITUTIONAL EXPERIENCE TO PREDICT CALVARIAL BONE FLAP LOSS USING LONG-TERM OUTCOMES

von: Shannon S. Wu, BA

2022, in: Plastic and Reconstructive Surgery, Global Open

Wird geladen...
11

Circulating Tumor DNA Testing Supports Rapid Therapeutic Decision-Making in Metastatic Melanoma: A Case Report

von: Tapas Ranjan Behera

2022, in: Frontiers in Oncology

Wird geladen...
12

Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series

von: Lillian Sun

2018, in: Journal for ImmunoTherapy of Cancer

Wird geladen...
13

Titanium Mesh is Not an Adequate Long-term Option for Patients Undergoing Complex Cranial Defect Reconstruction: A Multi-institutional Study

von: Daniela Duarte Bateman, MD

2023, in: Plastic and Reconstructive Surgery, Global Open

Wird geladen...
14

MCL1 nuclear translocation induces chemoresistance in colorectal carcinoma

von: Dechen Fu

2022, in: Cell Death and Disease

Wird geladen...
15

432 Nemvaleukin alfa, a novel engineered IL-2 cytokine, in combination with the anti-PD-1 antibody pembrolizumab in patients with recurrent/metastatic head and neck squamous cell carcinoma (ION-01 study)

von: Yan Wang

2021, in: Journal for ImmunoTherapy of Cancer

Wird geladen...
16

544 DELTA-1: A global, multicenter phase 2 study of ITIL-168, an unrestricted autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in adult patients with advanced cutaneous melanoma

von: Omid Hamid

2021, in: Journal for ImmunoTherapy of Cancer

Wird geladen...
17

776 Long-term efficacy and safety of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced melanoma: a 4-year analysis of the C-144–01 study

von: James Larkin

2023, in: Journal for ImmunoTherapy of Cancer

Wird geladen...
18

Abstract 50: Occlusal & Dental Outcomes Following Facial Allotransplantation

von: Demetrius M. Coombs, MD

2020, in: Plastic and Reconstructive Surgery, Global Open

Wird geladen...
19

An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0

von: Ryan J. Sullivan

2018, in: Journal for ImmunoTherapy of Cancer

Wird geladen...
20

Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence

von: Omid Hamid

2021, in: Journal for ImmunoTherapy of Cancer

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!